TRB3 mediates insulin/IGF-induced reactive oxygen species production, DNA damage, increase in S-phase fraction, evasion of apoptosis and proliferation in cancer cells, whereas silencing TRB3 impedes the malignancy-promoting actions. The gene discussed is INS; the disease is cancer.